Benjamin F. Edwards & Company’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $0 | Buy |
1,150
+300
| +35% | – | ﹤0.01% | 2227 |
|
|
2024
Q1 | $1K | Hold |
850
| – | – | ﹤0.01% | 2091 |
|
|
2023
Q4 | $0 | Hold |
850
| – | – | ﹤0.01% | 2168 |
|
|
2023
Q3 | $1K | Hold |
850
| – | – | ﹤0.01% | 1724 |
|
|
2023
Q2 | $1K | Hold |
850
| – | – | ﹤0.01% | 1730 |
|
|
2023
Q1 | $1K | Hold |
850
| – | – | ﹤0.01% | 1744 |
|
|
2022
Q4 | $3K | Hold |
850
| – | – | ﹤0.01% | 1692 |
|
|
2022
Q3 | $4K | Sell |
850
-1,500
| -64% | -$7.06K | ﹤0.01% | 1611 |
|
|
2022
Q2 | $10K | Hold |
2,350
| – | – | ﹤0.01% | 1386 |
|
|
2022
Q1 | $14K | Hold |
2,350
| – | – | ﹤0.01% | 1303 |
|
|
2021
Q4 | $18K | Hold |
2,350
| – | – | ﹤0.01% | 1267 |
|
|
2021
Q3 | $21K | Hold |
2,350
| – | – | ﹤0.01% | 1220 |
|
|
2021
Q2 | $28K | Hold |
2,350
| – | – | ﹤0.01% | 1152 |
|
|
2021
Q1 | $29K | Hold |
2,350
| – | – | ﹤0.01% | 1134 |
|
|
2020
Q4 | $37K | Buy |
2,350
+850
| +57% | +$13.4K | ﹤0.01% | 1041 |
|
|
2020
Q3 | $14K | Hold |
1,500
| – | – | ﹤0.01% | 1197 |
|
|
2020
Q2 | $13K | Hold |
1,500
| – | – | ﹤0.01% | 1224 |
|
|
2020
Q1 | $10K | Hold |
1,500
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q4 | $13K | Hold |
1,500
| – | – | ﹤0.01% | 1355 |
|
|
2019
Q3 | $14K | Hold |
1,500
| – | – | ﹤0.01% | 1309 |
|
|
2019
Q2 | $16K | Hold |
1,500
| – | – | ﹤0.01% | 1270 |
|
|
2019
Q1 | $14K | Buy |
+1,500
| New | +$14K | ﹤0.01% | 1239 |
|